Webinars

Join us for an exclusive webinar designed to showcase how our excipients can facilitate the development of innovative small molecules and OTC products. This webinar will provide a comprehensive introduction to our product offerings, along with technical insights and formulation benefits. Highlights: • Oral hygiene formulation solutions • Solutions for oral drug delivery • Topical drug delivery systems: formulating the future • Natural phospholipids and functional food ingredients

Advancements in small molecule therapeutics are transforming veterinary medicine by offering targeted, effective treatments for a range of animal health conditions. This webinar, Veterinary solutions for Small Molecule applications, will explore developments in formulation, and application of small molecules for companion and livestock animals.

Triton™X-100*の代替品、ウイルス不活化及び細胞溶解に向けて、クローダのVirodex™シリーズはお客様の研究開発にどのようなことを貢献できるのを説明します。

Learn more about how we can work together to solve your formulation challenges. Please note that this webinar is tailored for the Indonesian market; the slides are displayed in English but the speakers are presenting in Indonesian.

- Triton™ X-100 and its current limitations - What's needed for a successful detergent in bioprocessing - Our solution, Virodex™ product range: efficient and sustainable alternatives to Triton™ X-100 Triton™ X-100, a detergent often utilised in biomanufacturing, has been banned (with exemptions) in Europe effective January 2021 because of its harmful environmental impact. To address this issue, we have identified two sustainable alternatives that are compendial-grade, cGMP EXCiPACT-maufactured, REACH-compliant materials. This presentation will highlight that these alternatives exhibit equivalent performance to Triton™ X-100 fir viral inactivation and cell lysis and outperform other market alternatives for viral inactivation.

Discover our formulation solutions for cannabinoids.

高度精製（Super Refined™ ）医薬品添加剤のバイオ医薬品への応用について説明します。

核酸のデリバリー、ワクチン製剤の課題と新たなソリューションについて説明します。

Explore the key challenges within the oral drug delivery space and discover our formulation solutions, together we can unlock new pack claims and support the development of innovative formulations.

Global experts, Peter Tygesen and Dr. Dennis Christensen invite you to attend our webinar created for the vaccine developers, exploring key challenges faced by formulators in this space and diving into the adjuvant system solutions provided by Croda Pharma, to unlock novel vaccines of the future. There is a missing link between academic research and readily available GMP vaccine adjuvants. Novel adjuvants are being researched intensely, they are desperately needed to initiate additional immune responses and administration routes, to name a few. If the industry can come together to bridge this gap it will make GMP vaccine adjuvants commercially available for all, imagine the innovation that can be achieved! Let us come together to explore the solutions. We are passionate about addressing this challenge. We are providing the GMP adjuvant solutions for vaccines of today and innovating to develop adjuvants that unlock new possibilities for the novel vaccines of tomorrow.

Unlocking the vaccines of the future means developing the right delivery systems and immunostimulators today. In essence vaccination is all about presenting sufficient amounts of the right antigen, in the right conformation, to the right cells, while supporting with the right co-stimuli, for a sufficient amount of time. While modern vaccines, to a large extent, consist of highly purified recombinant proteins, synthetic peptides or nucleotides like mRNA, vaccine delivery systems and immunostimulatory components play an increasingly critical role in vaccine efficacy, whether for prophylactic or therapeutic purposes. Join our Immunostimulation webinar to learn about everything from the history of vaccines to the science of immunostimulation.

É com grande satisfação que retornamos com mais uma edição do Pharma Talks. Dessa vez, vamos abordar os desafios existentes durante o desenvolvimento de produtos farmacêuticos a base de canabidiol. Para essa discussão, contaremos com a participação da Professora Margarete Kishi (especialista no assunto), e Verônica Blanco, Cientista Líder de Aplicações da Croda Pharma.

Join this PharmaTalks webinar to learn about developing topical drug products that drive patient compliance. We will discuss how to deliver great sensory and aesthetic outcomes, so that they can work, not just in clinical trials, but in the hands of the patient. HLB, Polymer Microgel emulsions, Liquid Crystalline Lamellar Gel Network, and more will be discussed during this hour-long learning opportunity! - The different stabilization theories  - The HLB system - Case studies - Stability, aesthetics, and delivery of a topical drug

Descubra como nossos ingredientes podem maximizar suas formulações orais e tópicas!

Discover our range of webinars for oral and topical formulations, and how our ingredients can help you develop your brand. Each webinar contains tailored content, not only in local language but to support local needs.

Formulating and delivering a drug through oral administration is a preferred method for its convenience, versatility, and efficacy. However, it also comes with its set of challenges such as product stability, degradation upon ingestion, and drug uptake. These issues can hinder product efficacy and can sometimes mean the difference between having to take one capsule versus multiple. Tune in to this webinar to find out how we, as a formulations solution provider, respond to the challenges of the oral delivery of complex APIs with our Oral Lipid Delivery platform. Learn more about our recent launch of 4 new ingredients that are designed to meet the needs of the oral formulators.

経口剤によるドラッグデリバリーは利便性や汎用性、有効性から好まれる方法です。しかし、経口剤開発には、製剤の安定性、摂取時の分解、薬剤の吸収などの課題があります。これらの課題により製剤の有効性が妨げられ、時には単体のカプセル服用が、複数のカプセル服用になることもあります。 今回のウェビナーでは、製剤ソリューションプロバイダーであるクローダが、経口脂質デリバリープラットフォームを用いて、複雑なAPIの経口デリバリーの課題にどのように対応しているかをご紹介します。また、最近発売された4つの新原料についてもご紹介します。これらは、経口製剤メーカーのニーズを満たすように設計されています。

Wonder how you can optimise the performance and efficacy of your veterinary formulations? Croda offers functional speciality excipients for the following areas of veterinary pharmaceuticals & vaccines R&D development. Join our specialist in the field of veterinary health as she takes you through our laboratory and describes more about the knowledge, expertise, and lab facilities we have. These have enabled us to understand issues at hand, conduct analytical studies and investigations, and provide our customers with just the support and solutions they need.​

The discussions revolving around vaccine development are now more prevalent than ever. Immunisation has also become a global health and development success story, saving millions of lives each year*. *Source: World Health Organisation (WHO) Join our specialists in the field of the human vaccine on a live webinar this October to discover how Croda Health Care has evolved amidst one of the worst global pandemics in history and how our high-quality vaccine adjuvants and pharmaceutical excipients continue to serve as solutions for our customers for nearly a century.

Dr. Rumbelow will discuss the key role polysorbates play in stabilizing biopharmaceutical formulations and their excellent performance in preventing protein aggregation across a huge range of biopharmaceutical activities. Croda, established in 1925 is known for some of our best selling and most studied excipients, polysorbates. Steve will cover the complex nature of polysorbates and how differences in purity levels in the various grades of commercially available polysorbate can impact performance. In addition, how the various grades and indeed specific components of polysorbates, can impact formulation stability, including changes in formulation stability and issues around protein self-aggregation.